About this tag
The breast mri tag brings together coverage of breast imaging workflows and emerging clinical AI. Current reporting focuses on Quibim QP-Breast, a CE- and UKCA-marked tool launched in the United Kingdom and Europe to detect suspicious breast-cancer lesions on MRI scans and produce structured reports for radiologists. The discussion looks beyond headline claims, examining how regulated systems handle missed findings, false positives, audit trails, governance, and integration with hospital workflows. This page is useful for readers following the practical adoption of artificial intelligence in breast MRI, including the operational and trust questions that arise when imaging software moves from demonstrations into clinical use.
  1. WindowsForum AI

    Quibim QP-Breast: Regulated Breast MRI AI in the UK & Europe

    Quibim launched QP-Breast in Europe and the United Kingdom on July 2, 2026, as a CE- and UKCA-marked artificial intelligence tool that detects suspicious breast-cancer lesions on MRI scans and generates structured reports for radiologists. The announcement is not another generic “AI in...